A Polygenic Risk Score for Predicting Racial and Genetic Susceptibility to Prurigo Nodularis

被引:12
|
作者
Vasavda, Chirag [1 ,2 ]
Wan, Guihong [3 ,4 ]
Szeto, Mindy D. [2 ]
Marani, Melika [2 ]
Sutaria, Nishadh [2 ]
Rajeh, Ahmad [3 ]
Lu, Chenyue [3 ,4 ]
Lee, Kevin K. [2 ]
Nguyen, Nga T. T. [3 ]
Adawi, Waleed [2 ]
Deng, Junwen [2 ]
Parthasarathy, Varsha [2 ]
Bordeaux, Zachary A. [2 ]
Taylor, Matthew T. [2 ]
Alphonse, Martin P. [2 ]
Kwatra, Madan M. [5 ]
Kang, Sewon [2 ]
Semenov, Yevgeniy R. [3 ]
Gusev, Alexander [6 ,7 ]
Kwatra, Shawn G. [2 ,8 ,9 ]
机构
[1] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA
[2] Johns Hopkins Univ, Dept Dermatol, Sch Med, Baltimore, MD USA
[3] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA USA
[4] Harvard Med Sch, Dept Biomed Informat, Boston, MA USA
[5] Duke Univ, Sch Med, Dept Anesthesiol, Durham, NC USA
[6] Brigham & Womens Hosp, Div Genet, Boston, MA USA
[7] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA
[8] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD USA
[9] Johns Hopkins Univ, Dept Dermatol, Sch Med, 1550 Orleans St,Canc Res Bldg 2,Suite 206, Baltimore, MD 21231 USA
基金
美国国家卫生研究院;
关键词
GENOME-WIDE ASSOCIATION; DISEASE BURDEN; CELLS; BARRIER;
D O I
10.1016/j.jid.2023.04.033
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Prurigo nodularis (PN) is an understudied inflammatory skin disease characterized by pruritic, hyperkeratotic nodules. Identifying the genetic factors underlying PN could help to better understand its etiology and guide the development of therapies. In this study, we developed a polygenic risk score that predicts a diagnosis of PN (OR = 1.41, P = 1.6 x 10-5) in two independent and continentally distinct populations. We also performed GWASs, which uncovered genetic variants associated with PN, including one near PLCB4 (rs6039266: OR = 3.15, P = 4.8 x 10-8) and others near TXNRD1 (rs34217906: OR = 1.71, P = 6.4 x 10-7; rs7134193: OR = 1.57, P = 1.1 x 10-6). Finally, we discovered that Black patients have over a two-times greater genetic risk of developing PN (OR = 2.63, P = 7.8 x 10-4). Combining the polygenic risk score and self-reported race together was significantly predictive of PN (OR = 1.32, P = 4.7 x 10-3). Strikingly, this association was more significant with race than after adjusting for genetic ancestry. Because race is a sociocultural construct and not a genetically bound category, our findings suggest that genetics, environmental influence, and social determinants of health likely affect the development of PN and may contribute to clinically observed racial disparities.
引用
收藏
页码:2416 / +
页数:12
相关论文
共 50 条
  • [21] Validation of a prostate cancer polygenic risk score
    Black, Mary H.
    Li, Shuwei
    LaDuca, Holly
    Lo, Min-Tzu
    Chen, Jefferey
    Hoiness, Robert
    Gutierrez, Stephanie
    Tippin-Davis, Brigette
    Lu, Hsiao-Mei
    Gielzak, Marta
    Wiley, Kathleen
    Shi, Zhuqing
    Wei, Jun
    Zheng, Siqun Lilly
    Helfand, Brian T.
    Isaacs, William
    Xu, Jianfeng
    PROSTATE, 2020, 80 (15): : 1314 - 1321
  • [22] Polygenic score prediction captures nearly all common genetic risk for Alzheimer's disease
    Escott-Price, Valentina
    Shoai, Maryam
    Pither, Richard
    Williams, Julie
    Hardy, John
    NEUROBIOLOGY OF AGING, 2017, 49 : 214.e7
  • [23] Genetic risk sum score comprised of common polygenic variation is associated with body mass index
    Peterson, Roseann E.
    Maes, Hermine H.
    Holmans, Peter
    Sanders, Alan R.
    Levinson, Douglas F.
    Shi, Jianxin
    Kendler, Kenneth S.
    Gejman, Pablo V.
    Webb, Bradley T.
    HUMAN GENETICS, 2011, 129 (02) : 221 - 230
  • [24] A polygenic risk score for breast cancer risk in a Taiwanese population
    Hsieh, Yi-Chen
    Tu, Shih-Hsin
    Su, Chien-Tien
    Cho, Er-Chieh
    Wu, Chih-Hsiung
    Hsieh, Mao-Chih
    Lin, Shiyng-Yu
    Liu, Yun-Ru
    Hung, Chin-Sheng
    Chiou, Hung-Yi
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 163 (01) : 131 - 138
  • [25] Unidentified Genetic Variants Influence Pancreatic Cancer Risk: An Analysis of Polygenic Susceptibility in the PanScan Study
    Pierce, Brandon L.
    Tong, Lin
    Kraft, Peter
    Ahsan, Habibul
    GENETIC EPIDEMIOLOGY, 2012, 36 (05) : 517 - 524
  • [26] A Weighted Polygenic Risk Score Using 14 Known Susceptibility Variants to Estimate Risk and Age Onset of Psoriasis in Han Chinese
    Yin, Xianyong
    Cheng, Hui
    Lin, Yan
    Wineinger, Nathan E.
    Zhou, Fusheng
    Sheng, Yujun
    Yang, Chao
    Li, Pan
    Li, Feng
    Shen, Changbing
    Yang, Sen
    Schork, Nicholas J.
    Zhang, Xuejun
    PLOS ONE, 2015, 10 (05):
  • [27] Interactions between a Polygenic Risk Score and Non-genetic Risk Factors in Young-Onset Breast Cancer
    Shi, M.
    O'Brien, K. M.
    Weinberg, C. R.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [28] Polygenic risk score prediction of antipsychotic dosage in schizophrenia
    Hettige, Nuwan C.
    Cole, Christopher B.
    Khalid, Sarah
    De Luca, Vincenzo
    SCHIZOPHRENIA RESEARCH, 2016, 170 (2-3) : 265 - 270
  • [29] Clinical Application of Polygenic Risk Score in IgA Nephropathy
    Xu, Linlin
    Gan, Ting
    Chen, Pei
    Liu, Yang
    Qu, Shu
    Shi, Sufang
    Liu, Lijun
    Zhou, Xujie
    Lv, Jicheng
    Zhang, Hong
    PHENOMICS, 2024, 4 (02): : 146 - 157
  • [30] A Weighted Genetic Risk Score Using Known Susceptibility Variants to Predict Graves Disease Risk
    Ma, Yu-Ru
    Zhao, Shuang-Xia
    Li, Lu
    Sun, Feng
    Ye, Xiao-Ping
    Yuan, Fei-Fei
    Jiang, Dan
    Zhou, Zheng
    Zhang, Qian-Yue
    Wan, Yue-Yue
    Zhang, Guang-Ya
    Wu, Jing
    Zhang, Rui-Jia
    Fang, Ya
    Song, Huai-Dong
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (06): : 2121 - 2130